91 related articles for article (PubMed ID: 7941780)
61. Antisense oligodeoxynucleotide to delta opioid receptors blocks cocaine-induced place preference in mice.
Suzuki T; Tsuji M; Ikeda H; Misawa M; Narita M; Tseng LF
Life Sci; 1997; 60(20):PL 283-8. PubMed ID: 9150423
[TBL] [Abstract][Full Text] [Related]
62. Regulation of mu binding sites after chronic administration of antibodies directed against specific anti-opiate peptides.
Goodman CB; Heyliger S; Emilien B; Partilla JS; Yang HY; Lee CH; Cadet JL; Rothman RB
Peptides; 1998; 19(10):1703-9. PubMed ID: 9880075
[TBL] [Abstract][Full Text] [Related]
63. Behavioral and neurochemical effects of the new opioid peptide dynorphin--(1-13): comparison with other neuropeptides.
Zwiers H; Aloyo VJ; Gispen WH
Life Sci; 1981 Jun; 28(22):2545-51. PubMed ID: 6265732
[No Abstract] [Full Text] [Related]
64. Dynorphin A-(1-13) potently improves galanin-induced impairment of memory processes in mice.
Kameyama T; Ukai M; Miura M
Neuropharmacology; 1994 Oct; 33(10):1167-9. PubMed ID: 7532287
[TBL] [Abstract][Full Text] [Related]
65. Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice.
Itoh J; Ukai M; Kameyama T
Eur J Pharmacol; 1993 Mar; 234(1):9-15. PubMed ID: 8097164
[TBL] [Abstract][Full Text] [Related]
66. Intrathecal beta-funaltrexamine (beta-FNA) is a long acting agonist in the mouse abdominal stretch test.
Heyman JS; Porreca F
Proc West Pharmacol Soc; 1987; 30():209-10. PubMed ID: 3628278
[No Abstract] [Full Text] [Related]
67. The effect of halogenation on blood-brain barrier permeability of a novel peptide drug.
Gentry CL; Egleton RD; Gillespie T; Abbruscato TJ; Bechowski HB; Hruby VJ; Davis TP
Peptides; 1999; 20(10):1229-38. PubMed ID: 10573295
[TBL] [Abstract][Full Text] [Related]
68. Cocaine and opioid use during pregnancy: prevalence and management.
Bhuvaneswar CG; Chang G; Epstein LA; Stern TA
Prim Care Companion J Clin Psychiatry; 2008; 10(1):59-65. PubMed ID: 18311423
[No Abstract] [Full Text] [Related]
69. The role of the dynorphin/κ opioid receptor system in anxiety.
Hang A; Wang YJ; He L; Liu JG
Acta Pharmacol Sin; 2015 Jul; 36(7):783-90. PubMed ID: 25982631
[TBL] [Abstract][Full Text] [Related]
70. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence.
Smelson D; Yu L; Buyske S; Gonzalez G; Tischfield J; Deutsch CK; Ziedonis D
Am J Addict; 2012; 21(5):411-5. PubMed ID: 22882391
[TBL] [Abstract][Full Text] [Related]
71. The role of kappa-opioid receptor activation in mediating antinociception and addiction.
Wang YH; Sun JF; Tao YM; Chi ZQ; Liu JG
Acta Pharmacol Sin; 2010 Sep; 31(9):1065-70. PubMed ID: 20729876
[TBL] [Abstract][Full Text] [Related]
72. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
[TBL] [Abstract][Full Text] [Related]
73. Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement.
Ward SJ; Roberts DC
Behav Brain Res; 2007 Aug; 182(1):140-4. PubMed ID: 17572514
[TBL] [Abstract][Full Text] [Related]
74. Opioid peptides selective for receptor types modulate cocaine-induced behavioral responses in mice.
Ukai M; Mizutani M; Kameyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):153-9. PubMed ID: 7941780
[TBL] [Abstract][Full Text] [Related]
75. Differential modulation of behavioral responses by [D-Ala2, NMePhe4, Gly-ol]enkephalin, [D-Ala2] deltorphin II and [D-Pen2, L-Pen5]enkephalin in the mouse.
Ukai M; Toyoshi T; Mizutani M; Sasaki Y; Kameyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):161-8. PubMed ID: 7941781
[TBL] [Abstract][Full Text] [Related]
76. DAMGO ([D-Ala2,NMePhe4,Gly-ol]enkephalin), but not DPLPE ([D-Pen2,L- Pen5]enkephalin), specifically inhibits methamphetamine-induced behavioral responses in the mouse.
Ukai M; Toyoshi T; Kameyama T
Neuropharmacology; 1993 Oct; 32(10):1019-24. PubMed ID: 8295712
[TBL] [Abstract][Full Text] [Related]
77. Intrastriatal injection of opioid receptor agonists inhibits apomorphine-induced behavior in 6-hydroxydopamine-treated mice.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1995 Dec; 294(2-3):637-43. PubMed ID: 8750728
[TBL] [Abstract][Full Text] [Related]
78. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists.
Shippenberg TS; Rea W
Pharmacol Biochem Behav; 1997 Jul; 57(3):449-55. PubMed ID: 9218269
[TBL] [Abstract][Full Text] [Related]
79. Behavioral effects of food-derived opioid-like peptides in rodents: Implications for schizophrenia?
Lister J; Fletcher PJ; Nobrega JN; Remington G
Pharmacol Biochem Behav; 2015 Jul; 134():70-8. PubMed ID: 25661529
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
